Spyre Therapeutics (SYRE) Common Equity (2015 - 2026)
Spyre Therapeutics' Common Equity was $1.1 billion in Q2 2026, up 141.6% from $455.77 million a year earlier and up 64.2% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Spyre Therapeutics came in at $715.24 million, up 38.1% from FY2024.
- Common Equity has now increased for three consecutive years, with a five-year compound annual growth rate of 38.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $517.8 million in FY2024 (+181.4%), $184.02 million in FY2023 (+265.8%), $50.31 million in FY2022 (-40.1%) and $83.94 million in FY2021 (-40.0%).
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2015.
- Compared with a year earlier, Common Equity has increased for seven straight quarters, with growth averaging 96.8% over the last seven quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2024 (growth of 352.5%); the worst was Q1 2022 (a decline of 50.2%).
- Per Business Quant data, SYRE's Common Equity in the three quarters before Q2 2026 was $670.81 million (Q1 2026), $715.24 million (Q4 2025) and $455.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Spyre Therapeutics | 7.84 Bn | 7.84 Bn | - | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 670.81 Mn |
| Dec 31, 2025 | 715.24 Mn |
| Sep 30, 2025 | 455.10 Mn |
| Jun 30, 2025 | 455.77 Mn |
| Mar 31, 2025 | 482.61 Mn |
| Dec 31, 2024 | 517.80 Mn |
| Sep 30, 2024 | 327.39 Mn |
| Jun 30, 2024 | 374.39 Mn |
| Mar 31, 2024 | 152.27 Mn |
| Dec 31, 2023 | 184.02 Mn |
| Sep 30, 2023 | -245.40 Mn |
| Jun 30, 2023 | -207.37 Mn |
| Mar 31, 2023 | 33.65 Mn |
| Dec 31, 2022 | 50.31 Mn |
| Sep 30, 2022 | 67.56 Mn |
| Jun 30, 2022 | 84.16 Mn |
| Mar 31, 2022 | 61.66 Mn |
| Dec 31, 2021 | 83.94 Mn |
| Sep 30, 2021 | 102.08 Mn |
API Access
Spyre Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();